Late relapse of primary central nervous system lymphoma.

about

Late relapse of primary central nervous system lymphoma.

Item

http://www.wikidata.org/entity/Q48631019

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Late relapse of primary central nervous system lymphoma.

@en

Late relapse of primary central nervous system lymphoma.

@nl

type

Item

label

Late relapse of primary central nervous system lymphoma.

@en

Late relapse of primary central nervous system lymphoma.

@nl

prefLabel

Late relapse of primary central nervous system lymphoma.

@en

Late relapse of primary central nervous system lymphoma.

@nl

P1476

Late relapse of primary central nervous system lymphoma.

@en

P2093

Atsushi Kawaguchi

http://www.w3.org/2001/XMLSchema#string

Hiroaki Hondoh

http://www.w3.org/2001/XMLSchema#string

Hiroshi Aoki

http://www.w3.org/2001/XMLSchema#string

Hitoshi Takahashi

http://www.w3.org/2001/XMLSchema#string

Jumpei Homma

http://www.w3.org/2001/XMLSchema#string

Katsuhiko Akiyama

http://www.w3.org/2001/XMLSchema#string

Ken Morii

http://www.w3.org/2001/XMLSchema#string

Manabu Natsumeda

http://www.w3.org/2001/XMLSchema#string

Masakazu Sano

http://www.w3.org/2001/XMLSchema#string

Naoki Yajima

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome

Late relapse in primary central nervous system lymphoma: clonal persistence

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.

Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough?

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.

Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.

Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series.

Relapse of primary CNS lymphoma after more than 10 years in complete remission.

P304

475-477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2016.1201570

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ryuya Yamanaka

P577

2016-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27397141

http://www.w3.org/2001/XMLSchema#string